Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial

Name: Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial
Published: 2007
License: Public Domain

Acorda Therapeutics · 2007

ClinicalTrials.gov · Datasets · License: Public Domain · 2007

Open Source ↗

ms multiple-sclerosis walking

multiple sclerosis, ms, walking, leg strength, demyelination, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial

Related documents